Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Physiol Res ; 66(6): 1061-1065, 2017 12 20.
Artigo em Inglês | MEDLINE | ID: mdl-28937244

RESUMO

AT(1) receptor (AT1R) blockade prevents physiological cardiac hypertrophy induced by resistance training. Also, our group showed that a single bout of resistance exercise (RE) activates the AKT/mTOR which was also inhibited by AT1R blocker. Here, we investigated whether IGF1-receptor (IGF1-R) and MAPKs were also activated after a single bout of RE. Wistar rats were divided into Sedentary (Sed), Sedentary treated with losartan (Sed+LOS), Exercise (EX), and Exercise treated with losartan (EX+LOS). Cardiac tissue was obtained 5 and 30 min after 4 sets of 12 repetitions of squat exercise (80 % 1RM). We demonstrated that a single bout of RE did not induce IGF1-R tyrosine phosphorylation. ERK1/2 and P38 phosphorylation levels were elevated in the EX 5min and EX 30min groups however, only ERK1/2 was inhibited by losartan treatment (AT1R blocker). Next, we showed that beta-arrestin-2 expression increased 28 % in trained animals compared to sedentary group. Altogether, our results demonstrate that AT1R, but not IGF1-R, may exert the hypertrophic cardiac stimulus RE-induced. Also, activation of AKT/mTOR and ERK1/2 pathways may occur through the beta-arrestin-dependent pathway.


Assuntos
Cardiomegalia Induzida por Exercícios , Miocárdio/metabolismo , Condicionamento Físico Animal/métodos , Receptor Tipo 1 de Angiotensina/metabolismo , Receptor IGF Tipo 1/metabolismo , Treinamento Resistido , Transdução de Sinais , Bloqueadores do Receptor Tipo 1 de Angiotensina II/farmacologia , Animais , Cardiomegalia Induzida por Exercícios/efeitos dos fármacos , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Losartan/farmacologia , Masculino , Ratos Wistar , Receptor Cross-Talk , Receptor Tipo 1 de Angiotensina/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Fatores de Tempo , beta-Arrestina 2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...